CWM
VVOS icon

Centurion Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

Centurion Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2K Hold
35,684
– – ﹤0.01% 283
2026
Q1 		$42.1K Buy
+35,684
New +$57.2K 0.01% 316

Other funds holding VVOS

BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
KA
Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Centurion Wealth Management's VVOS Position: Q2 2026 in Review

Centurion Wealth Management held its Vivos Therapeutics (VVOS) position steady in Q2 2026 at 35,684 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Centurion Wealth Management first reported a position in VVOS in Q1 2026 and has held it in 2 quarters since. The position peaked at $42.1K in Q1 2026. 4 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Centurion Wealth Management held 35,684 shares of Vivos Therapeutics worth $16.2K as of Q2 2026.
  • Centurion Wealth Management left its Vivos Therapeutics share count unchanged in Q2 2026.
  • Vivos Therapeutics made up ﹤0.01% of Centurion Wealth Management's portfolio in Q2 2026, its #283 holding.
  • Centurion Wealth Management first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Centurion Wealth Management's Vivos Therapeutics position peaked at $42.1K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.